InterCure Ltd. Form 6-K Summary
Business Context and Reporting Period
InterCure Ltd., an Israeli foreign private issuer, filed Form 6-K for December 2022. The filing is dated December 19, 2022 and identifies Exhibit 99.1 as a press release dated December 19, 2022. The filing does not include the substantive text of the press release.
Financial Metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, operating performance, or other financial metrics.
Material Changes Versus Prior Period
The filing text does not provide information sufficient to assess changes versus a prior comparable period.
Guidance, Outlook, Risks, and Unusual Items
The filing text does not provide management guidance, outlook commentary, risk disclosures, contingencies, or unusual items. Any such information may be contained in Exhibit 99.1, which is listed but not included in the supplied text.
Investor Verification Items
- Obtain and review Exhibit 99.1, the December 19, 2022 press release.
- Verify whether the press release contains operating results, financial guidance, financing information, or material corporate developments.
- Review the company’s applicable Form 20-F and other reports for complete financial statements and liquidity information.